These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20117197)

  • 61. Rheological Characteristics of Novel Meloxicam-Loaded Complex Organogels Based on Fumed Silica and Poloxamer.
    Osmalek T; Froelich A; Jadach B; Ancukiewicz K; Gadzinski P
    Curr Drug Deliv; 2018; 15(5):686-697. PubMed ID: 29165081
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Improving tenoxicam solubility and bioavailability by cosolvent system.
    Yeh MK; Chang LC; Chiou AH
    AAPS PharmSciTech; 2009; 10(1):166-71. PubMed ID: 19224373
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Particle size reduction using acoustic cavitation].
    Bartos C; Ambrus R; Szabóné RP
    Acta Pharm Hung; 2014; 84(4):131-5. PubMed ID: 25872275
    [TBL] [Abstract][Full Text] [Related]  

  • 64. PPF microsphere depot sustains NSAID blood levels with infusion-like kinetics without 'burst'.
    Shang Q; Wang X; Apley M; Kukanich SB; Berkland C
    J Vet Pharmacol Ther; 2012 Jun; 35(3):231-8. PubMed ID: 21696401
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Biowaiver studies of newly optimized meloxicam tablets.
    Zafar F; Khan S; Ali H; Shah SN; Bushra R; Naqvi GR; Maroof K; Khan MA; Nisa Z
    Pak J Pharm Sci; 2018 Jul; 31(4(Supplementary)):1469-1474. PubMed ID: 30058537
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Design and characteristics of gellan gum beads for modified release of meloxicam.
    Osmałek T; Milanowski B; Froelich A; Szybowicz M; Białowąs W; Kapela M; Gadziński P; Ancukiewicz K
    Drug Dev Ind Pharm; 2017 Aug; 43(8):1314-1329. PubMed ID: 28420283
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Deconvolution analysis for absorption and metabolism of aspirin in microcapsules.
    Wu X; Yamashita F; Hashida M
    Biol Pharm Bull; 1999 Nov; 22(11):1212-6. PubMed ID: 10598030
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacokinetics of cyclosporine and steady-state aspirin during coadministration.
    Kovarik JM; Mueller EA; Gaber M; Johnston A; Jähnchen E
    J Clin Pharmacol; 1993 Jun; 33(6):513-21. PubMed ID: 8366176
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Investigation of permeability of intranasal formulations using Side-Bi-Side horizontal diffusion cell].
    Horváth Tamás ; Ambrus R; Szabóné RP
    Acta Pharm Hung; 2015; 85(1):19-28. PubMed ID: 26137783
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Preparation and in vitro/in vivo evaluation of microparticle formulations containing meloxicam.
    Eroglu H; Burul-Bozkurt N; Uma S; Oner L
    AAPS PharmSciTech; 2012 Mar; 13(1):46-52. PubMed ID: 22101966
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Computational Models of the Gastrointestinal Environment. 2. Phase Behavior and Drug Solubilization Capacity of a Type I Lipid-Based Drug Formulation after Digestion.
    Birru WA; Warren DB; Han S; Benameur H; Porter CJ; Pouton CW; Chalmers DK
    Mol Pharm; 2017 Mar; 14(3):580-592. PubMed ID: 27936778
    [TBL] [Abstract][Full Text] [Related]  

  • 72. In-house reference materials: 5-hydroxyflunixin and meloxicam in cow milk-preparation and evaluation.
    Jedziniak P; Szprengier-Juszkiewicz T; Olejnik M
    Anal Chim Acta; 2009 Apr; 637(1-2):346-50. PubMed ID: 19286050
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Lipid-based formulations for danazol containing a digestible surfactant, Labrafil M2125CS: in vivo bioavailability and dynamic in vitro lipolysis.
    Larsen A; Holm R; Pedersen ML; Müllertz A
    Pharm Res; 2008 Dec; 25(12):2769-77. PubMed ID: 18592356
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Solvation and hydration characteristics of ibuprofen and acetylsalicylic acid.
    Perlovich GL; Kurkov SV; Kinchin AN; Bauer-Brandl A
    AAPS PharmSci; 2004 Jan; 6(1):E3. PubMed ID: 15198504
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of suspension composition on the pharmacokinetics of nimesulide in rats.
    Carrasco-Portugal Mdel C; Flores-Murrieta FJ
    Proc West Pharmacol Soc; 2008; 51():58-9. PubMed ID: 19544678
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Influence of seven beverages on salicylate disposition in humans.
    Odou P; Barthélémy C; Robert H
    J Clin Pharm Ther; 2001 Jun; 26(3):187-93. PubMed ID: 11422602
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Application of hydroalcoholic solutions of formaldehyde in preparation of acetylsalicylic acid gastro-resistant capsules.
    Pina ME; Sousa AT
    Drug Dev Ind Pharm; 2002 Apr; 28(4):443-9. PubMed ID: 12056537
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Design, characterization, and evaluation of meloxicam gel prepared by suspension and solution polymerization using solubility parameter as the basis for development.
    Jain D; Pathak K
    AAPS PharmSciTech; 2010 Mar; 11(1):133-42. PubMed ID: 20077041
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Study of nimesulide release from solid pharmaceutical formulations in tween 80 solutions.
    Purcaru SO; Ionescu M; Raneti C; Anuta V; Mircioiu I; Belu I
    Curr Health Sci J; 2010 Jan; 36(1):42-9. PubMed ID: 24778826
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Enhancement of Docetaxel Absorption Using Ritonavir in an Oral Milk-Based Formulation.
    Soulele K; Karampelas T; Tamvakopoulos C; Macheras P
    Pharm Res; 2021 Aug; 38(8):1419-1428. PubMed ID: 34382143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.